Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

Delayed Quote. Delayed  - 06/23 02:23:12 pm
12.04 EUR   +1.18%
05/09 CYTOTOOLS : withdraws planned convertible bond
04/25 CYTOTOOLS : Ad hoc Capital increase
04/25 CYTOTOOLS : Capital increase
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/19/2017 06/20/2017 06/21/2017 06/22/2017 06/23/2017 Date
11.905(c) 12(c) 11.895(c) 11.9(c) 12.04(c) Last
2 070 1 632 2 101 234 1 675 Volume
+2.28% +0.80% -0.88% +0.04% +1.18% Change
More quotes
Company
CytoTools AG is an investment holding company, which engages in the development of therapies to treat cause of diseases.It provides treatment options in dermatology, cardiology and angiology, urology, and oncology.Its pipeline includes DermaPro, CardioClean, LMW 0x, HMW 02Ac, and Utisept.The... 
More about the company
Latest news on CYTOTOOLS AG
05/09 CYTOTOOLS : withdraws planned convertible bond
04/25 CYTOTOOLS : Capital increase
04/25 CYTOTOOLS : Ad hoc Capital increase
04/21 DGAP-NEWS : CytoTools AG schafft mit Kapitalerhöhung die Voraussetzung zur Umset..
04/21 DGAP-ADHOC : CytoTools AG schafft mit einer Barkapitalerhöhung die Voraussetzung..
04/07 DGAP-NEWS : Produktionsstart in Indien
03/30 DGAP-ADHOC : Ausgabe einer Wandelanleihe mit einem Gesamtnennbetrag von bis zu 0..
03/24 DGAP-NEWS : CytoTools AG: DermaPro(R) erhält Marktzulassung in Indien - ein Meil..
03/24 DGAP-ADHOC : CytoTools AG: DermaPro(R) erhält Marktzulassung in Indien
02/16 DGAP-NEWS : CytoTools AG setzt erneut Patentschutz für DermaPro(R) durch
More news
Sector news : Bio Therapeutic Drugs
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
06/15DJACTELION : J&J Maps Research Plans for Actelion -- WSJ
06/14DJACTELION : Correction to J&J Actelion Story
06/14DJACTELION : J&J Plans to Add Drug Discovery and Early Research to Actelion Unit
More sector news : Bio Therapeutic Drugs
Latest Tweets
05/09CytoTools : withdraws planned convertible bond  
2016CytoTools : DermaTools action for damages  
2016#Frankfurt #stocks: CytoTools : #Market Analysts conclude unsteady sales prof.. 
2016BRIEF-Cytotools unit signs contracts for production with German manufacturer ..
1
2016#Frankfurt #stocks: CytoTools : #Merger #Acquisition Analysts say: thin Feb 2.. 
More tweets
Qtime:4
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Managers
NameTitle
Mark-Andre Freyberg Chief Executive Officer
Manfred May Chairman-Supervisory Board
Wilfried Hauke Chief Medical Officer
Matthias Hoffmann Member-Supervisory Board
Bernhard Seehaus Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYTOTOOLS AG40.02%28
AMGEN17.98%126 856
CELGENE CORPORATION16.03%104 873
GILEAD SCIENCES-1.52%92 150
REGENERON PHARMACEUTIC..43.43%54 987
VERTEX PHARMACEUTICALS83.97%33 251
More Results